title: Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients.
authors.affiliation: Sandoz AG, Clinical Research, Nürnberg, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Färber
authors.forename: A
authors.initials: A
authors.lastname: Maibücher
authors.forename: F
authors.initials: F
authors.lastname: Geissler
authors.forename: F
authors.initials: F
authors.lastname: Gutzler
authors.forename: F O
authors.initials: FO
authors.lastname: Wiesinger
authors.forename: M
authors.initials: M
authors.lastname: Winkler
mesh_terms: D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005260:Female; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007408:Intestinal Absorption; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged
chemical_list: D016572:Cyclosporine; D003404:Creatinine; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase